Home » Newsletters » BioWorld Science

BioWorld Science

June 17, 2004

View Archived Issues

Antitumor effects of CpG-7909 in several types of human cancer

Synthetic Australian snake venom derivative effective for wound healing

Restoration of CFTR function with SV40 gene therapy

Antitumor effects and safety of rhLF in advanced cancer patients

Novel potent and selective 5-HT2C agonists for the treatment of obesity discovered at Wyeth

Study results on GLP-1 analogue CJC-1131 presented during ADA

Synergistic effects of IL-21 and rituximab in B-lymphoma cell lines

An EGF vaccine reported to improve survival in advanced lung cancer

Positive preliminary phase III results for Sativex in neuropathic pain

Crucell enters PER.C6 licensing agreement with Chiron

FDA accepts IND for stem cell mobilizing drug CTCE-0214

Sosei's phase I trial of SOU-001 cleared to begin in U.K.

First patient enrolled in phase I/II study of TheraCIM hR3 for pediatric glioma

ZYC-101a shows 100% efficacy in patients with high-grade cervical dysplasia

Pivotal phase III trial of Rencarex for renal cell carcinoma opens enrollment

Symadex enters phase I in patients with advanced solid tumors

SVT-40776 progresses into phase II for urinary incontinence

Daily Infergen plus ribavirin evaluated for HCV in new DIRECT trial

Ovation acquires Buronil from Lundbeck

IR-103 enters first clinical study for HIV

First phase IIa patients receive BrachySil for liver cancer

Two series of gamma-secretase inhibitors identified at Merck

AstraZeneca presents novel PTP-1B inhibitors

Boehringer Ingelheim scientists describe new ICAM-1/LFA-1 interaction inhibitors

Dual alpha7 nAChR agonists/5-HT3 antagonists for psychosis, cognition disorders, etc.

New antilipolytic agents targeting hRUP38 receptors

T-614 reported safe and effective in patients with active rheumatoid arthritis

Novel chemokine CCR1 antagonists and their use covered by Pfizer patent

New monoamine reuptake inhibitors developed at NeuroSearch

Preliminary data on the efficacy of epratuzumab in SLE

Clinical response found with eculizumab in rheumatoid arthritis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...